VERA CIK: 1831828

Vera Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
82.5
FY22:
126
FY23:
172
FY24:
651
FY25:
729
(positive)
Change from FY21 to FY25
millions USD
FY21:
1.21
FY22:
5.74
FY23:
3.52
FY24:
4.46
FY25:
5.85
Total assets
Change from FY21 to FY25
millions USD
FY21:
83.7
FY22:
131
FY23:
176
FY24:
656
FY25:
735

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
7.69
FY22:
25.6
FY23:
22.3
FY24:
25.4
FY25:
53.5
(negative)
Change from FY21 to FY25
millions USD
FY21:
6.47
FY22:
28.9
FY23:
51.6
FY24:
53.2
FY25:
76.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
69.6
FY22:
76.9
FY23:
102
FY24:
577
FY25:
605
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
83.7
FY22:
131
FY23:
176
FY24:
656
FY25:
735

All amounts in millions USD Data source:SEC EDGAR